See also this year's filing and all EDGAR filings for this company.
PDF Report 0001424812_2015_Amarantus_Bioscience_Holdings_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| warning | Expenses in unusual place in relation to revenue | input.sec.calculation_linkbase.edgar_model_mapping | {'expenses_node': 'OperatingExpenses', 'revenue_node': 'SalesRevenueGoodsNet', 'net_inc_node': 'NetIncomeLoss'} |
Graph
Absolute values for 0001424812, Amarantus Bioscience Holdings Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 412,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,497,000 |
| 2 | PropertyPlantAndEquipmentNet | 145,000 |
| 3 | remainder_Assets | 204,000 |
| 4 | LiabilitiesCurrent | 6,329,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,592,000 |
| 9 | ResearchAndDevelopmentExpense | 13,762,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -5,923,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,258,000 |
| 1 | Liabilities | 6,329,000 |
| 2 | Expenses | 21,354,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -4,071,000 |
| 5 | NetIncome | -27,277,000 |
| 6 | ComprehensiveNetIncome | -27,277,000 |
| 7 | BaseVar | 17,932,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -8.42 |
| 9 | EconomicCapitalRatio | 0.00485 |
Edgar->Model Mapping
Feature Distribution
